SE8703972L - Ogondroppar - Google Patents

Ogondroppar

Info

Publication number
SE8703972L
SE8703972L SE8703972A SE8703972A SE8703972L SE 8703972 L SE8703972 L SE 8703972L SE 8703972 A SE8703972 A SE 8703972A SE 8703972 A SE8703972 A SE 8703972A SE 8703972 L SE8703972 L SE 8703972L
Authority
SE
Sweden
Prior art keywords
eyedrops
concentration
humectant
dry eye
rheological properties
Prior art date
Application number
SE8703972A
Other languages
English (en)
Other versions
SE8703972D0 (sv
SE503469C2 (sv
Inventor
D Shabtay
Original Assignee
Res & Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11057204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8703972(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res & Dev Co Ltd filed Critical Res & Dev Co Ltd
Publication of SE8703972D0 publication Critical patent/SE8703972D0/sv
Publication of SE8703972L publication Critical patent/SE8703972L/sv
Publication of SE503469C2 publication Critical patent/SE503469C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8703972A 1986-10-14 1987-10-13 Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol SE503469C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL80298A IL80298A (en) 1986-10-14 1986-10-14 Eye drops

Publications (3)

Publication Number Publication Date
SE8703972D0 SE8703972D0 (sv) 1987-10-13
SE8703972L true SE8703972L (sv) 1988-04-15
SE503469C2 SE503469C2 (sv) 1996-06-24

Family

ID=11057204

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703972A SE503469C2 (sv) 1986-10-14 1987-10-13 Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol

Country Status (8)

Country Link
US (1) US5106615A (sv)
CA (1) CA1311418C (sv)
DE (1) DE3734835C2 (sv)
FR (1) FR2604906B1 (sv)
GB (1) GB2196255B (sv)
IL (1) IL80298A (sv)
IT (1) IT1211852B (sv)
SE (1) SE503469C2 (sv)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323522A4 (en) * 1987-07-07 1989-08-30 Santen Pharmaceutical Co Ltd ARTIFICIAL TEAR.
JPH05503527A (ja) * 1990-02-22 1993-06-10 マクノート・ピーティーワイ・リミテッド 人工涙液
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
DE4225489A1 (de) * 1992-07-30 1994-02-03 Michael Prof Dr Rer Na Dittgen Verfahren zur Herstellung bioadhäsiver Augentropfen
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
US5645827A (en) * 1992-09-30 1997-07-08 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
FR2717691B1 (fr) * 1994-03-22 1998-02-13 Europhta Laboratoire Nouveaux gels ophtalmiques et leur procédé d'obtention.
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
IT1274984B (it) * 1994-12-09 1997-07-29 Technopharma Sa Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
JP4421681B2 (ja) * 1995-10-19 2010-02-24 バイオ‐オリジン エルエルシー 生殖細胞および胚の生存および機能を改善する方法および組成物
IT1277707B1 (it) 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
WO1997045102A1 (en) * 1996-05-31 1997-12-04 Schwadrohn, Gérard Novel therapeutic use of ophthalmic gels
US5840046A (en) * 1996-06-21 1998-11-24 Medtronic, Inc. Guidewire having hydrophilic coating
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6277365B1 (en) 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
WO1999059634A1 (fr) * 1998-05-15 1999-11-25 Wakamoto Pharmaceutical Co., Ltd. Gouttes oculaires anti-inflammatoires
JP2002538124A (ja) 1999-03-01 2002-11-12 ヴィスタ サイエンティフィック エルエルシー ムチンを含む眼科用調合物
US6703039B2 (en) 2000-12-06 2004-03-09 Bausch & Lomb Incorporated Reversible gelling system for ocular drug delivery
US6878694B2 (en) 2000-12-20 2005-04-12 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US6656460B2 (en) 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
PT1474109E (pt) 2001-12-21 2010-10-25 Alcon Inc Utilização de nanopartículas inorgânicas sintéticas como veículos em medicamentos oftálmicos
KR20040073503A (ko) * 2001-12-21 2004-08-19 알콘, 인코퍼레이티드 안과용 및 이과용 약제학적 조성물의 점도 및 기타물리학적 성질을 개질시키기 위한 무기 나노입자의 용도
IL165910A0 (en) * 2002-07-03 2006-01-15 Pericor Science Inc Compositions of hyaluronic acid and methods of use
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
EP1651161B1 (en) 2003-08-07 2011-10-19 HealOr Ltd. Pharmaceutical compositions and methods for accelerating wound healing
PL1654002T5 (pl) 2003-08-07 2014-06-30 Allergan Inc Kompozycje do dostarczania środków terapeutycznych do oczu
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050209606A1 (en) * 2004-02-26 2005-09-22 Dharmendra Jani Alginate viscoelastic composition, method of use and package
US7842382B2 (en) * 2004-03-11 2010-11-30 Knauf Insulation Gmbh Binder compositions and associated methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
WO2006017347A2 (en) * 2004-07-12 2006-02-16 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
EP2147686A1 (en) * 2004-10-01 2010-01-27 Menicon Co., Ltd. Method for packaging contact lenses
US8603631B2 (en) * 2004-10-13 2013-12-10 Knauf Insulation Gmbh Polyester binding compositions
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US9297928B2 (en) 2004-11-22 2016-03-29 Johnson & Johnson Vision Care, Inc. Ophthalmic compositions comprising polyether substituted polymers
WO2006085351A1 (en) * 2005-02-09 2006-08-17 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
IL168603A (en) † 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
US10183076B2 (en) 2005-05-16 2019-01-22 Resdevco Research And Development Co. L Topical compositions for treatment of irritation of mucous membranes
ES2732298T3 (es) * 2005-07-26 2019-11-21 Knauf Insulation Gmbh Un método de fabricación de productos de aislamiento de fibra de vidrio
ZA200802546B (en) * 2005-08-29 2009-10-28 Healor Ltd Methods and compositions for prvention and treatment of diabetic and aged skin
FR2895907B1 (fr) * 2006-01-06 2012-06-01 Anteis Sa Gel viscoelastique a usage dermatologique
EP1988936B1 (en) 2006-02-17 2014-08-06 Novartis AG Ophtalmic product and method for sterilization
CN101668713B (zh) 2007-01-25 2012-11-07 可耐福保温材料有限公司 矿物纤维板
BRPI0721232B1 (pt) 2007-01-25 2023-01-24 Knauf Insulation Limited Placa de madeira compósita
PL2108006T3 (pl) 2007-01-25 2021-04-19 Knauf Insulation Gmbh Spoiwa i wytworzone z nich materiały
DK2826903T3 (da) 2007-01-25 2023-06-06 Knauf Insulation Fremgangsmåde til fremstilling af mineralfiberisoleringsprodukt
EP2109594A1 (en) * 2007-01-25 2009-10-21 Knauf Insulation Limited Mineral fibre insulation
EP2137223B1 (en) * 2007-04-13 2019-02-27 Knauf Insulation GmbH Composite maillard-resole binders
US10028976B2 (en) 2007-07-02 2018-07-24 Aptissen Sa Injectable formulation of natural polysaccharide and polyol for treatment of osteoarthritis
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
CA2692489A1 (en) * 2007-07-05 2009-01-08 Knauf Insulation Gmbh Hydroxymonocarboxylic acid-based maillard binder
CN102755649A (zh) * 2007-07-30 2012-10-31 希尔洛有限公司 药物组合物及相关方法
GB0715100D0 (en) 2007-08-03 2007-09-12 Knauf Insulation Ltd Binders
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
US20170354624A1 (en) * 2007-11-14 2017-12-14 Resdevco Research And Development Co. Ltd. Topical compositions for treatment of skin irritation
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
CA2770396A1 (en) 2009-08-07 2011-02-10 Knauf Insulation Molasses binder
DK2506831T3 (da) 2009-12-03 2013-12-16 Alcon Res Ltd Carboxyvinylpolymerholdige nanopartikelsuspensioner
EP2523677A2 (en) 2010-01-11 2012-11-21 Healor Ltd. Method for treatment of inflammatory disease and disorder
JP5992903B2 (ja) 2010-05-07 2016-09-14 ナフ インサレーション エセペーアールエル 炭水化物結合剤およびそれを用いて作製される材料
KR102023264B1 (ko) 2010-05-07 2019-11-04 크나우프 인설레이션, 인크. 탄수화물 폴리아민 결합제 및 이를 이용하여 제조된 물질
US20130082205A1 (en) 2010-06-07 2013-04-04 Knauf Insulation Sprl Fiber products having temperature control additives
FR2961694B1 (fr) 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
RU2013117209A (ru) 2010-11-08 2014-10-27 Хилор Лтд. Буферные глазные композиции и способы их применения
IL212725A (en) * 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
US20140186635A1 (en) 2011-05-07 2014-07-03 Knauf Insulation Liquid high solids binder composition
GB201206193D0 (en) 2012-04-05 2012-05-23 Knauf Insulation Ltd Binders and associated products
GB201214734D0 (en) 2012-08-17 2012-10-03 Knauf Insulation Ltd Wood board and process for its production
CA2892900C (en) 2012-12-05 2020-08-11 Benedicte Pacorel Method for manufacturing an article comprising a collection of matter bound by a cured binder
AU2014209346B2 (en) 2013-01-23 2018-11-15 Semnur Pharmaceuticals, Inc. Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
US20140378401A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
PL3102587T3 (pl) 2014-02-07 2019-01-31 Knauf Insulation, Inc. Nieutwardzone wyroby o ulepszonym okresie trwałości
GB201408909D0 (en) 2014-05-20 2014-07-02 Knauf Insulation Ltd Binders
TWI674899B (zh) 2015-01-21 2019-10-21 美商桑紐爾製藥公司 醫藥配方
GB201517867D0 (en) 2015-10-09 2015-11-25 Knauf Insulation Ltd Wood particle boards
GB201610063D0 (en) 2016-06-09 2016-07-27 Knauf Insulation Ltd Binders
GB201701569D0 (en) 2017-01-31 2017-03-15 Knauf Insulation Ltd Improved binder compositions and uses thereof
IL269133B1 (en) 2017-03-05 2024-05-01 Resdevco Res And Development Co Ltd Eye drops for the treatment of irritation without infection
GB201804908D0 (en) 2018-03-27 2018-05-09 Knauf Insulation Ltd Binder compositions and uses thereof
GB201804907D0 (en) 2018-03-27 2018-05-09 Knauf Insulation Ltd Composite products
WO2021156856A1 (en) 2020-02-03 2021-08-12 Resdevco Research And Development Co. Ltd. Topical opthalmological composition containing hyaluronate and taurine having non-newtonian rheological properties

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB904797A (en) * 1959-12-23 1962-08-29 Boots Pure Drug Co Ltd Ophthalmic medicaments comprising phenanthridinium salts
GB1044449A (en) * 1965-05-18 1966-09-28 Boots Pure Drug Co Ltd Improvements in ophthalmic preparations
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
DK159414C (da) * 1980-03-21 1991-03-18 Wellcome Found Isotonisk vaeskeformigt farmaceutisk praeparat indeholdende trimethoprim og polymyxin, samt fremgangsmaade til at goere et med en kviksoelvforbindelse konserveret farmaceutisk praeparat isotonisk
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
GB2090013B (en) * 1980-12-18 1984-04-11 Smith & Nephew Ass Soft contact lens sterilising solution
JPS5857319A (ja) * 1981-09-30 1983-04-05 Green Cross Corp:The 高粘性ヒアルロン酸製剤
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
WO1984004681A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
WO1984004680A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic gel
PH21406A (en) * 1985-04-19 1987-10-15 Ciba Geigy Ag Ophthalmic solution and methods for improving the comfort and safety of contact lenses
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate

Also Published As

Publication number Publication date
SE8703972D0 (sv) 1987-10-13
GB2196255A (en) 1988-04-27
GB2196255B (en) 1991-05-15
US5106615A (en) 1992-04-21
IL80298A0 (en) 1987-01-30
SE503469C2 (sv) 1996-06-24
DE3734835A1 (de) 1988-06-01
IL80298A (en) 1993-01-31
FR2604906A1 (fr) 1988-04-15
IT1211852B (it) 1989-11-03
DE3734835C2 (de) 1997-07-17
CA1311418C (en) 1992-12-15
FR2604906B1 (fr) 1992-02-07
IT8748495A0 (it) 1987-10-13
GB8724112D0 (en) 1987-11-18

Similar Documents

Publication Publication Date Title
SE8703972L (sv) Ogondroppar
DK0698388T3 (da) Oftalmisk præparat til anvendelse som kunstige tårer
PT92453A (pt) Processo para a preparacao de uma solucao oftalmica aquosa a base de dioxido de cloro e processo para a preservacao da mesma
ATE246508T1 (de) Lösungen für die peritonealdialyse, die maltodextrine und aminosäuren enthalten
KR960700081A (ko) 콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions)
DK0495421T3 (da) Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
DE69522550T2 (de) Flüssiges ophthalmologisches abgabesystem mit verzögerter freisetzung
SE9401108D0 (sv) Ophthalmic composition I
FR2636339B1 (fr) Gel aqueux a base d'acide hyaluronique et d'acide desoxyribonucleique utilisable en cosmetique, et procede de preparation
ATE220538T1 (de) Ophthalmologische zusammensetzung, die ein ionenempfindliches polymer und ein anorganisches salz in einem verhältnis enthält, das eine niedrige viskosität ergibt
SE8405464L (sv) Komposition for oftalmologiska applikationer
ATA150990A (de) Loesung von cellulose in wasser und n-methyl-morpholin-n-oxid
PT875248E (pt) Utilizacao do acido hialuronico para a preparacao de uma solucao aquosa util como liquido de lavagem intra-articular
PE22995A1 (es) Composicion de tiotepa liofilizada estable
ES2102175T3 (es) Combinaciones de polimeros para su utilizacion en lagrimas artificiales.
ES8103394A1 (es) Metodo para el tratamiento de las lentes de contacto.
CA1273296C (en) SOLUBLE COLLAGEN COMPOSITION
RU93042330A (ru) Способ получения глазных капель пилокарпина гидрохлорида пролонгированного действия

Legal Events

Date Code Title Description
NUG Patent has lapsed